The United States recorded 79,384 drug overdose deaths in 2024, according to the National Center for Health Statistics. That is a real fall. It is not a return to normal. [1]

Tuesday's paper framed the same problem as an overdose counter still sitting above the 2019 baseline. Today's receipt lets the paper write the more difficult sentence: the country can celebrate the fastest improvement in years and still be living with a death toll that would have looked intolerable before the pandemic-era surge.

The NCHS data brief says the age-adjusted overdose death rate fell 26.2 percent from 2023 to 2024, from 31.3 deaths per 100,000 standard population to 23.1. It calls that the largest annual decrease in the 10-year period shown. It also reports declines across age groups, sex, race and Hispanic-origin groups. [1]

The drug detail matters. NCHS says the rate involving synthetic opioids other than methadone fell 35.6 percent, from 22.2 to 14.3. Rates involving psychostimulants with abuse potential and cocaine also declined. For a decade in which fentanyl functioned as the grim center of the overdose story, that synthetic-opioid decline is not a footnote. It is the hinge. [1]

But the historical table keeps the victory honest. In 2019, before the great acceleration, overdose deaths numbered 70,630, with an age-adjusted rate of 21.6. In 2024, after the decline, deaths still numbered 79,384, with a rate of 23.1. The improvement is large enough to change policy conversations. The remaining burden is large enough to keep emergency rooms, families and county health departments from treating the crisis as over. [1]

The mainstream frame is statistical because it has to be. NCHS uses vital records, age-adjusted rates and drug categories. That method is dry, but it prevents the story from becoming merely anecdotal. A county can feel improvement and still need the national series to know whether the improvement is broad, durable and visible across groups.

X does what X does with good news that arrives late. One camp declares victory for enforcement, treatment, border policy, naloxone, medication-assisted treatment or some preferred combination. Another camp treats the drop as suspicious because institutions have not earned trust. A third camp insists that even talking about improvement insults the dead. Each response contains a human impulse. None is a substitute for the denominator.

The paper's position is simple: this is good news with a cruel baseline. A 26 percent one-year decline means fewer funerals, fewer families waiting on a coroner, fewer police officers knocking on doors. It also means 79,384 deaths, which is roughly 8,700 more than 2019.

The NCHS table also keeps the numerator plain: deaths fell from 106,699 in 2023, but the 2024 count still exceeds the pre-surge line [1].

That gap is where the next story lives. If the decline continues, 2024 becomes the year the overdose curve broke. If it stalls above the old baseline, the country will have converted an acute emergency into a chronic one and mistaken the change in slope for an ending.

-- NORA WHITFIELD, Chicago